"Therapy resistant" trang 1 - tải miễn phí từ tailieunhanh
Ebook Treatment-Resistant mood disorders: Part 2

Ebook Treatment-Resistant mood disorders: Part 2
90    84    0
Ebook Nelson’s pediatric antimicrobial therapy (24/E): Part 1

Ebook Nelson’s pediatric antimicrobial therapy (24/E): Part 1
186    95    0
Enzalutamide versus abiraterone as a first-line endocrine therapy for castrationresistant prostate cancer (ENABLE study for PCa): A study protocol for a multicenter randomized phase III trial

Enzalutamide versus abiraterone as a first-line endocrine therapy for castrationresistant prostate cancer (ENABLE study for PCa): A study protocol for a multicenter randomized phase III trial
6    68    1
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: Study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study)

Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: Study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study)
7    69    0
Delayed reduction of hepatitis B viral load and dynamics of adefovir resistant variants during adefovir plus entecavir combination rescue therapy

Delayed reduction of hepatitis B viral load and dynamics of adefovir resistant variants during adefovir plus entecavir combination rescue therapy
7    62    0
Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems

Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems
10    58    1
Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: An Italian multicenter “real life” study

Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: An Italian multicenter “real life” study
8    31    1
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
10    67    1
Bacteriological profile and antimicrobial resistance of blood culture isolates from a 350 bedded Hospital Lucknow, India

Bacteriological profile and antimicrobial resistance of blood culture isolates from a 350 bedded Hospital Lucknow, India
10    72    1
Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
15    23    1
Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer

Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer
10    45    1
Screening of genes encoding adhesion factors and biofilm production in methicillin resistant strains of Staphylococcus aureus isolated from Palestinian patients

Screening of genes encoding adhesion factors and biofilm production in methicillin resistant strains of Staphylococcus aureus isolated from Palestinian patients
12    48    1
Review Cannabis: A new strategy against methicillin-resistant Staphylococcus aureus

Review Cannabis: A new strategy against methicillin-resistant Staphylococcus aureus
9    15    1
Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan

Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan
10    7    1
Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy
8    59    1
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4

FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
14    45    1
Identification of novel drugs to target dormant micrometastases

Identification of novel drugs to target dormant micrometastases
12    30    1
Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer

Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer
11    42    1
Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer
13    19    1
Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis
7    18    1